EPISODE · Dec 18, 2023 · 11 MIN
Hemostemix Inc.
from OTCQB Podcast · host OTC Markets Group
Hemostemix Inc. (OTCQB: HMTXF) is a patient's own stem cell therapy company that holds 91 patents. A winner of the World Economic Forum Technology Pioneer Award, the Company has developed patented, and is scaling a patient's blood-based stem cell therapeutics platform. Thomas Smeenk, President, CEO and Co-Founder of Hemostemix, joins us today to share his personal story and inspiration for creating this company to help others. View Podcast Transcript
Embed this episode
Ready to play
Hemostemix Inc.
No transcript for this episode yet
Similar Episodes
No similar episodes found.